Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 10, 1996

View Archived Issues

GRF analogs under study at Tulane University

Benzothiophene compounds for women's health disclosed by Lilly

Merck & Co. reveals new agents for BPH

New antiinflammatory agents disclosed by DuPont Merck

Sugen reports antihyperproliferative agents

Merck Frosst's apopain inhibitors: A novel approach to multiple disorders

New neuroleptic agents reported by Ferrer

Japanese academic researchers isolate new quassinoid compound

Avitar's collection system marketed for DNA testing

U.S. market introduction for novel antifungal formulation

HemispheRx CFS diagnostic receives European patent approval

Roberts in-licenses another GI drug from Lilly

BMS reports results from cefprozil multicenter clinical study in AOM patients

P&U anticipates filing for urinary incontinence treatment soon

FDA approves new agent for spasticity

FemPatch approved for marketing in U.S.

CytRx subsidiary to merge with Zynaxis

Paracetamol safety established in pregnant mothers and their babies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...